Ferring’s Rebyota, a novel first-in-class microbiota-based live biotherapeutic, has been approved by the FDA for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback